Sweating The Little Things: European Companies Call On China to Overhaul Public Procurement System
This article was originally published in PharmAsia News
Executive Summary
They say misery loves company, so in one respect, biopharma and medical device companies can rest easy knowing that firms in seemingly every industry, from information technology firms to wind power equipment manufacturers, are struggling to make heads or tails of China's estimated $1 trillion public procurement market
You may also be interested in...
Chinese Government Takes First Steps To De-link Indigenous Innovation And Procurement, But Industry Groups Wary
SHANGHAI - Months after pledging a policy change, China is finally taking steps to break ties between indigenous innovation and government procurement policies. The changes in policy, according to a report released by the U.S.-China Business Council, address growing concern among multinationals that procurement policies - an estimated $1 trillion market - are increasingly designed to shut them out
Chinese Government Takes First Steps To De-link Indigenous Innovation And Procurement, But Industry Groups Wary
SHANGHAI - Months after pledging a policy change, China is finally taking steps to break ties between indigenous innovation and government procurement policies. The changes in policy, according to a report released by the U.S.-China Business Council, address growing concern among multinationals that procurement policies - an estimated $1 trillion market - are increasingly designed to shut them out
European Companies Concerned About Regulatory Environment in China - European Chamber Of Commerce Survey
HONG KONG - The rule of law and transparent policy-making and implementation will be the most important factors in China's economic performance in the years ahead, a survey of European companies shows